We have observed
6 EP applications
Ludovicus A.G.M. van den Broek
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 22, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Glatiramer acetate human monocytic cell line-based potency assay
COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
DUOCARMYCIN ADCS SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITY